Just a fraction of prescriptions for the abortion pill mifepristone were filled at brick-and-mortar retail pharmacies after federal drug regulators lifted longstanding dispensing limits, according to a new USC study in JAMA. The U.S. Food and Drug Administration (FDA) in January 2023 permanently removed rules requiring patients to obtain mifepristone—the first of two drugs used in medication abortion—in person at a clinic or hospital. That change meant in-store and mail-order pharmacies could provide the drug when it was prescribed by a certified provider, a shift expected to broaden access nationwide.
Continue Reading this article here
